- Home
- SPRU vs IGC Comparison
SPRU vs IGC Comparison
Compare SPRU & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRU
- IGC
- Stock Information
- Founded
- SPRU 2008
- IGC 2005
- Country
- SPRU United States
- IGC United States
- Employees
- SPRU N/A
- IGC N/A
- Industry
- SPRU Auto Parts:O.E.M.
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- SPRU Consumer Discretionary
- IGC Health Care
- Exchange
- SPRU Nasdaq
- IGC Nasdaq
- Market Cap
- SPRU 34.9M
- IGC 39.2M
- IPO Year
- SPRU N/A
- IGC N/A
- Fundamental
- Price
- SPRU $1.50
- IGC $0.44
- Analyst Decision
- SPRU
- IGC Strong Buy
- Analyst Count
- SPRU 0
- IGC 2
- Target Price
- SPRU N/A
- IGC $4.00
- AVG Volume (30 Days)
- SPRU 4.0M
- IGC 1.3M
- Earning Date
- SPRU 08-11-2025
- IGC 08-14-2025
- Dividend Yield
- SPRU N/A
- IGC N/A
- EPS Growth
- SPRU N/A
- IGC N/A
- EPS
- SPRU N/A
- IGC N/A
- Revenue
- SPRU $98,396,000.00
- IGC $1,327,000.00
- Revenue This Year
- SPRU $2.12
- IGC $15.26
- Revenue Next Year
- SPRU N/A
- IGC $3.41
- P/E Ratio
- SPRU N/A
- IGC N/A
- Revenue Growth
- SPRU 23.43
- IGC 24.95
- 52 Week Low
- SPRU $1.13
- IGC $0.25
- 52 Week High
- SPRU $3.25
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- SPRU 54.76
- IGC 67.66
- Support Level
- SPRU $1.43
- IGC $0.42
- Resistance Level
- SPRU $1.54
- IGC $0.47
- Average True Range (ATR)
- SPRU 0.08
- IGC 0.03
- MACD
- SPRU 0.02
- IGC 0.01
- Stochastic Oscillator
- SPRU 85.11
- IGC 73.27
About SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.